The stock of cbdMD Inc (YCBD) has gone up by 11.00% for the week, with a 15.53% rise in the past month and a 8.36% rise in the past quarter. The volatility ratio for the week is 14.13%, and the volatility levels for the past 30 days are 11.87% for YCBD. The simple moving average for the past 20 days is 2.95% for YCBD’s stock, with a -21.30% simple moving average for the past 200 days.
Is It Worth Investing in cbdMD Inc (AMEX: YCBD) Right Now?
The 36-month beta value for YCBD is at 1.97. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for YCBD is 3.12M, and currently, shorts hold a 9.00% of that float. The average trading volume for YCBD on November 15, 2024 was 108.33K shares.
YCBD) stock’s latest price update
cbdMD Inc (AMEX: YCBD)’s stock price has gone rise by 12.47 in comparison to its previous close of 0.45, however, the company has experienced a 11.00% increase in its stock price over the last five trading days. newsfilecorp.com reported 2024-11-14 that Charlotte, North Carolina–(Newsfile Corp. – November 14, 2024) – cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) a trusted leader in the wellness and cannabinoid industry, is excited to announce the launch of Herbal Oasis Social Tonics—a carefully crafted low-calorie, hemp derived THC seltzer line designed to elevate social occasions with a blend of premium cannabinoids and adaptogenic mushrooms. Available in four delicious flavors—Lemon Lift, Tropical Twist, Mango Bliss, and Berry Fusion—Herbal Oasis is designed to deliver an experience that enhances social connection and well-being, offering an alternative to traditional alcoholic drinks.
YCBD Trading at 4.72% from the 50-Day Moving Average
After a stumble in the market that brought YCBD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.55% of loss for the given period.
Volatility was left at 11.87%, however, over the last 30 days, the volatility rate increased by 14.13%, as shares surge +18.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.45% lower at present.
During the last 5 trading sessions, YCBD rose by +11.00%, which changed the moving average for the period of 200-days by -35.16% in comparison to the 20-day moving average, which settled at $0.4949. In addition, cbdMD Inc saw -51.01% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for YCBD
Current profitability levels for the company are sitting at:
- -0.88 for the present operating margin
- 0.61 for the gross margin
The net margin for cbdMD Inc stands at -0.99. The total capital return value is set at -3.03. Equity return is now at value -135.07, with -82.98 for asset returns.
Based on cbdMD Inc (YCBD), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -0.57. The debt to equity ratio resting at 0.46. The interest coverage ratio of the stock is -575.08.
Currently, EBITDA for the company is -7.47 million with net debt to EBITDA at -0.43. When we switch over and look at the enterprise to sales, we see a ratio of 0.18. The receivables turnover for the company is 22.53for trailing twelve months and the total asset turnover is 1.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.93.
Conclusion
In conclusion, cbdMD Inc (YCBD) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
